Items where authors include "Fragiadaki, M."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 14.

Article

Mullenger, J.L. orcid.org/0009-0002-3526-1270, Zeidler, M.P. and Fragiadaki, M. (2023) Evaluating the molecular properties and function of ANKHD1, and Its role in cancer. International Journal of Molecular Sciences, 24 (16). 12834. ISSN 1661-6596

Souilhol, C., Tardajos Ayllon, B., Li, X. et al. (21 more authors) (2022) JAG1-NOTCH4 mechanosensing drives atherosclerosis. Science Advances, 8 (35). eabo7958. ISSN 2375-2548

Evans, P.C., Fragiadaki, M., Morris, P.D. orcid.org/0000-0002-3965-121X et al. (1 more author) (2021) Shear stress : the dark energy of atherosclerotic plaques. Cardiovascular Research, 117 (8). pp. 1811-1813. ISSN 0008-6363

Fragiadaki, M. orcid.org/0000-0002-1587-5577, Macleod, F.M. and Ong, A.C.M. orcid.org/0000-0002-7211-5400 (2020) The controversial role of fibrosis in Autosomal Dominant Polycystic Kidney Disease. International Journal of Molecular Sciences, 21 (23). 8936. ISSN 1661-6596

Souilhol, C., Gauci, I., Feng, S. et al. (7 more authors) (2019) Homeobox B9 integrates bone morphogenic protein 4 with inflammation at atheroprone sites. Cardiovascular Research. ISSN 0008-6363

Xanthis, I., Souilhol, C., Serbanovic-Canic, J. et al. (15 more authors) (2019) β1 integrin is a sensor of blood flow direction. Journal of Cell Science, 132 (11). jcs229542. ISSN 0021-9533

Fragiadaki, M. orcid.org/0000-0002-1587-5577 and Evans, P.C. orcid.org/0000-0001-7975-681X (2019) The Bernard and Joan Marshall Early Career Investigators and Distinguished Investigator Award 2018. Cardiovascular Drugs and Therapy, 33 (2). pp. 203-205. ISSN 0920-3206

Patera, F., Cudzich-Madry, A., Huang, Z. et al. (1 more author) (2019) Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis. Scientific Reports, 9. 4491. ISSN 2045-2322

Fisher, K.H. orcid.org/0000-0002-2751-156X, Fragiadaki, M. orcid.org/0000-0002-1587-5577, Pugazhendhi, D. et al. (5 more authors) (2018) A genome-wide RNAi screen identifies MASK as a positive regulator of cytokine receptor stability. Journal of Cell Science, 131. jcs209551. ISSN 0021-9533

Fragiadaki, M. and Zeidler, M.P. (2018) Ankyrin repeat and Single KH domain 1 (ANKHD1) drives renal cancer cell proliferation via binding to and altering a subset of miRNAs. Journal of Biological Chemistry , 293. pp. 9570-9579. ISSN 0021-9258

Feng, S., Bowden, N., Fragiadaki, M. et al. (13 more authors) (2017) Mechanical activation of hypoxia-inducible factor 1α drives endothelial dysfunction at atheroprone sites. Arteriosclerosis, Thrombosis, and Vascular Biology, 37 (11). ISSN 1079-5642

Fragiadaki, M., Lannoy, M., Themanns, M. et al. (5 more authors) (2017) STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease. Kidney International. ISSN 0085-2538

Ikeda, T., Fragiadaki, M., Shi-wen, X. et al. (8 more authors) (2016) Data on CUX1 isoforms in idiopathic pulmonary fibrosis lung and systemic sclerosis skin tissue sections. Data in Brief, 8. C. pp. 1377-1380.

Ikeda, T., Fragiadaki, M., Shi-wen, X. et al. (8 more authors) (2016) Transforming growth factor-β-induced CUX1 isoforms are associated with fibrosis in systemic sclerosis lung fibroblasts. Biochemistry and Biophysics Reports, 7. pp. 246-252.

This list was generated on Sat Mar 23 17:03:42 2024 GMT.